Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

Corey Jay Langer, Shirish M. Gadgeel, Hossein Borghaei et al. · The Lancet Oncology · 2016

Cited by 1,403 works. doi:10.1016/s1470-2045(16)30498-3

Authors

References